# Coherus Oncology, Inc.: Form 8-K, filed Apr 22, 2025

- Company: [Coherus Oncology, Inc.](/companies/chrs.md) (CIK 1512762)
- Form: 8-K
- Filed: 2025-04-22
- Accepted by EDGAR: Apr 22, 2025, 17:07 ET
- Period: 2025-04-16
- Accession: 0001558370-25-005157
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1512762/000155837025005157/chrs-20250416x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1512762/000155837025005157/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1512762/000155837025005157/chrs-20250416x8k.htm

Filed Apr 22, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-005157. Last ingested by Listed: Oct 29, 2026, 08:11 ET. No prices; not investment advice.
